TAPINAROF for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 561 adverse event reports in the FDA FAERS database where TAPINAROF was used for Psoriasis.
Most Reported Side Effects for TAPINAROF
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Folliculitis | 281 | 20.3% | 0 | 1 |
| Pruritus | 165 | 11.9% | 0 | 1 |
| Headache | 142 | 10.2% | 0 | 1 |
| Dermatitis contact | 122 | 8.8% | 0 | 8 |
| Rash | 103 | 7.4% | 0 | 0 |
| Erythema | 94 | 6.8% | 0 | 1 |
| Drug ineffective | 80 | 5.8% | 0 | 0 |
| Skin burning sensation | 79 | 5.7% | 0 | 0 |
| Application site erythema | 54 | 3.9% | 0 | 3 |
| Application site pruritus | 54 | 3.9% | 0 | 0 |
| Application site pain | 50 | 3.6% | 0 | 0 |
| Application site folliculitis | 43 | 3.1% | 0 | 0 |
| Pain of skin | 42 | 3.0% | 0 | 1 |
| Hypersensitivity | 39 | 2.8% | 0 | 0 |
| Off label use | 39 | 2.8% | 0 | 0 |
Other Indications for TAPINAROF
Product used for unknown indication (49)
Dermatitis atopic (19)
Eczema (16)
Rash (9)
Dermatitis (6)
Lichen planopilaris (5)
Pruritus (5)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)